A full-service CRO, Cliantha Research offers integrated services across early phase (BA-BE and Phase I), late phase (II-IV), respiratory, dermatology, consumer clinical research, IVRT/IVPT biometrics, medical services, environmental exposure chambers and veterinary therapeutics. The company has been successfully inspected by regulators including the US FDA, EMA, AGES, ANSM, ANVISA, MCC South Africa, Health Canada, DCGI, CAP, NABL, Turkey's MOH, Thailand's MoPH and Malaysia's NPRA, with a presence in the USA, Canada, Europe and India.

Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen